77 related articles for article (PubMed ID: 17203997)
1. Characterization of monoclonal antibodies to human soluble MD-2 protein.
Viriyakosol S; McCray PB; Ashbaugh ME; Chu J; Jia HP; Weiss J; Kirkland TN
Hybridoma (Larchmt); 2006 Dec; 25(6):349-57. PubMed ID: 17203997
[TBL] [Abstract][Full Text] [Related]
2. MD-2-dependent human Toll-like receptor 4 monoclonal antibodies detect extracellular association of Toll-like receptor 4 with extrinsic soluble MD-2 on the cell surface.
Tsukamoto H; Ihara H; Ito R; Ukai I; Suzuki N; Kimoto M; Tomioka Y; Ikeda Y
Biochem Biophys Res Commun; 2013 Oct; 440(1):31-6. PubMed ID: 24021278
[TBL] [Abstract][Full Text] [Related]
3. Recombinant soluble forms of extracellular TLR4 domain and MD-2 inhibit lipopolysaccharide binding on cell surface and dampen lipopolysaccharide-induced pulmonary inflammation in mice.
Mitsuzawa H; Nishitani C; Hyakushima N; Shimizu T; Sano H; Matsushima N; Fukase K; Kuroki Y
J Immunol; 2006 Dec; 177(11):8133-9. PubMed ID: 17114488
[TBL] [Abstract][Full Text] [Related]
4. Multiple potential regulatory sites of TLR4 activation induced by LPS as revealed by novel inhibitory human TLR4 mAbs.
Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Ihara H; Ikeda Y; Kimoto M
Int Immunol; 2012 Aug; 24(8):495-506. PubMed ID: 22499954
[TBL] [Abstract][Full Text] [Related]
5. Isolation of monomeric and dimeric secreted MD-2. Endotoxin.sCD14 and Toll-like receptor 4 ectodomain selectively react with the monomeric form of secreted MD-2.
Teghanemt A; Widstrom RL; Gioannini TL; Weiss JP
J Biol Chem; 2008 Aug; 283(32):21881-9. PubMed ID: 18519568
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of agonistic monoclonal antibodies against Toll-like receptor 4-MD-2 complex.
Bahrun U; Kimoto M; Tsukamoto H; Tsuneyoshi N; Kohara J; Fukudome K
Hybridoma (Larchmt); 2007 Dec; 26(6):393-9. PubMed ID: 18158784
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
[TBL] [Abstract][Full Text] [Related]
8. A designed TLR4/MD-2 complex to capture LPS.
Brandl K; Glück T; Hartmann P; Salzberger B; Falk W
J Endotoxin Res; 2005; 11(4):197-206. PubMed ID: 16176655
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 region Glu24-Lys47 is a site for MD-2 binding: importance of CYS29 and CYS40.
Nishitani C; Mitsuzawa H; Sano H; Shimizu T; Matsushima N; Kuroki Y
J Biol Chem; 2006 Dec; 281(50):38322-9. PubMed ID: 17056597
[TBL] [Abstract][Full Text] [Related]
10. Mannose binding lectin and lung collectins interact with Toll-like receptor 4 and MD-2 by different mechanisms.
Shimizu T; Nishitani C; Mitsuzawa H; Ariki S; Takahashi M; Ohtani K; Wakamiya N; Kuroki Y
Biochim Biophys Acta; 2009 Dec; 1790(12):1705-10. PubMed ID: 19840833
[TBL] [Abstract][Full Text] [Related]
11. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
12. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2.
Visintin A; Halmen KA; Latz E; Monks BG; Golenbock DT
J Immunol; 2005 Nov; 175(10):6465-72. PubMed ID: 16272300
[TBL] [Abstract][Full Text] [Related]
14. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS.
Zou Y; Qin F; Chen J; Meng J; Wei L; Wu C; Zhang Q; Wei D; Chen X; Wu H; Chen X; Dai S
Oncotarget; 2016 Aug; 7(32):52032-52044. PubMed ID: 27409669
[TBL] [Abstract][Full Text] [Related]
15. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells.
Blais DR; Vascotto SG; Griffith M; Altosaar I
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of membrane and soluble forms of human MD-2.
Viriyakosol S; Tobias PS; Kirkland TN
J Biol Chem; 2006 Apr; 281(17):11955-64. PubMed ID: 16467306
[TBL] [Abstract][Full Text] [Related]
17. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.
Ohnishi T; Muroi M; Tanamoto K
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960
[TBL] [Abstract][Full Text] [Related]
18. Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomerization of TLR4 required for signal transduction.
Tsuneyoshi N; Kohara J; Bahrun U; Saitoh S; Akashi S; Gauchat JF; Kimoto M; Fukudome K
Cell Immunol; 2006 Nov; 244(1):57-64. PubMed ID: 17420011
[TBL] [Abstract][Full Text] [Related]
19. Increased release of sMD-2 during human endotoxemia and sepsis: a role for endothelial cells.
Wolfs TG; Dunn-Siegrist I; van't Veer C; Hodin CM; Germeraad WT; van Zoelen MA; van Suylen RJ; Peutz-Kootstra CJ; Elson G; Pugin J; Buurman WA
Mol Immunol; 2008 Jun; 45(11):3268-77. PubMed ID: 18384879
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.
Tsukamoto H; Fukudome K; Takao S; Tsuneyoshi N; Kimoto M
Int Immunol; 2010 Apr; 22(4):271-80. PubMed ID: 20133493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
